Suspension and Cancellation of Certificates and Operating Licences in Panama
Updated: 2026-11-11 · GRZAN Regulatory Team · Verification date 2026-10-20
1. Key takeaways
Article 66 of Decreto Ejecutivo N° 490 lists five grounds on which a CCT or CVT may be suspended, Article 67 lists thirteen grounds on which it may be cancelled, and Article 69 governs the operating licence, where suspension lasts six months and a second occurrence leads to cancellation, with six suspension grounds and seven cancellation grounds set out in the same article. Every suspension and cancellation must be issued by a duly reasoned resolution (resolución debidamente motivada) and notified in accordance with Ley 38 de 31 de julio de 2000.
- Two regimes — product credentials fall under Articles 66 to 68 and the operating licence under Article 69, with different grounds.
- Manufacturer change cancels — a change of manufacturer is a cancellation ground for the certificate, not a variation to be recorded.
- Withdrawal of authority cancels — loss of the manufacturer’s authorisation to sell or distribute is likewise a cancellation ground.
- Family certificates can be pruned — Article 68 allows one affected device to be removed by resolution rather than losing the whole certificate.
- Six months then cancellation — the licence regime is progressive, and a second suspension ground removes discretion.
- Notification reaches procurement — Article 72 requires notice to the National Register of Bidders and all public health institutions.
2. Legal basis
Articles 66, 67 and 68 of DE 490 of 4 October 2019 deal with product certificates, Article 69 with the operating licence, and Articles 71 and 72 with the form and notification of the decision.
| Decreto Ejecutivo N° 490 (4 October 2019) | Article 66 | CCT or CVT suspension, five grounds: 1. investigation, on a confirmed health risk, of a device incident, potential adverse event or failure; 2. investigation for failure to meet the requirements for issuance; 3. other circumstances recommended by DNDM; 4. other circumstances recommended by the health authority and its dependent agencies; 5. discovery of modifications to marketed devices that were not reported to the authorised technical unit or to the DNDM that issued the certificate |
| Same | Article 67 | CCT or CVT cancellation, thirteen grounds: 1. reasoned request of the holder; 2. change of manufacturer; 3. documents submitted with the application, or the certificate itself, proven falsified or adulterated; 4. unreported modifications to marketed devices; 5. recommendation through the vigilance system by a national or international authority; 6. prohibition of use in the country of origin for health reasons; 7. quality problems, an appearance differing from the evaluated product, contamination or faults capable of harming health, including at storage and/or distribution; 8. investigation confirming that the device caused the suspected incident, potential adverse event or failure; 9. withdrawal by the manufacturer of the supplier’s authorisation to sell or distribute its devices; 10. DNDM establishing that the CVT or CCT has been falsified; 11. failure by the company to honour the commitments in its sworn statement; 12. other circumstances established by DNDM regulation; 13. other circumstances recommended by the health authority and its dependent agencies |
| Same | Article 68 | Family certificates are suspended or cancelled on the same grounds as individual devices; where one device in a family is suspended or cancelled, it must be removed from the certificate by resolution and the corresponding modification processed |
| Same | Article 69, first paragraph | Suspension or cancellation of the licence removes the marketing qualification of all devices and related products covered by it, whether or not their sanitary registrations are valid |
| Same | Article 69, middle part | Six suspension grounds (falsified documents, use of forged certificates in public procurement, activity outside the authorised scope without reporting, failure to honour the sworn statement, inspection finding defects or anomalies endangering device safety and quality, other circumstances set by DNDM resolution); suspension lasts six months from notification of the resolution; a second occurrence leads to cancellation |
| Same | Article 69, final part | Seven cancellation grounds (request of the holder, death of a natural person or dissolution of a legal person, permanent loss of capacity to trade, repetition of a suspension ground, criminal or administrative penalty by final judgment resulting in permanent closure, judicially declared bankruptcy or insolvency, other circumstances set by DNDM resolution) |
| Same | Article 71 | Suspension or cancellation of the licence requires a reasoned resolution, notified in accordance with Ley 38 de 31 de julio de 2000 and the general administrative procedure rules in force |
| Same | Article 72 | After suspension or cancellation of a CVT, CCT or licence, the legal representative or agent must be notified and the Comisión Nacional de Registro Nacional de Oferentes and all public health institutions informed |
3. Expert insights
Insight one: change of manufacturer is a cancellation ground under Article 67, item 2, and that shapes how holding structures are arranged. The official wording is Cuando cambie el fabricante: when the manufacturer changes, the CCT is cancelled rather than amended. In the same way, item 9, the manufacturer’s withdrawal of the supplier’s authorisation to sell or distribute, also produces cancellation. The two items mean that a Panamanian CCT is tightly bound to the manufacturer and supplier pair, and a change at either end causes the certificate to fall away. A supply chain that switches production site transmits that decision directly into the regulatory status of the product.
Insight two: the notification mechanism in Article 72 connects certificate status to public procurement eligibility. Suspension or cancellation must be notified to the National Register of Bidders and to all public health institutions. Certificate status therefore affects the ability to take part in public procurement, since the Certificado de Oferente is one of the general documents required by Article 36, item 5. The commercial consequence of a credential lapsing is not confined to the private market, and it arrives through an administrative notification rather than a commercial negotiation.
Insight three: the partial removal mechanism for family certificates in Article 68 is a practical design. Where one device within a family certificate is suspended or cancelled, the product must be removed from the certificate by resolution and the modification processed, rather than the entire certificate falling. This preserves the compliance status of the remaining products and gives the holder a route to contain a single-product problem. The mechanism works only if used promptly, since leaving an affected device on the certificate invites a dispute about the whole family.
Insight four: the six-month suspension followed by cancellation on repetition is a progressive penalty structure. The official text reads: La suspensión será por un periodo de seis meses contados a partir de la notificación de la resolución. En caso de reincidencia (entiéndase por segunda vez) en alguna causal de suspensión se procederá con la cancelación de la licencia de operaciones. A second triggering of any suspension ground leads to cancellation, with no discretion left at that point. The first suspension is therefore the last opportunity to remediate, and remediation must be completed within the six-month period rather than begun within it.
4. Practical recommendations
- Assess the consequences of any change in the manufacturer and supplier relationship, so that a change of site or representative does not cancel the certificate.
- Include stability terms in distribution authorisation agreements with manufacturers, and agree a notice period before any withdrawal of authority.
- Where a single device in a family certificate runs into difficulty, apply proactively for removal under Article 68 to protect the remaining products.
- Treat the first suspension as a deadline rather than a warning, and complete remediation within the six-month period to avoid cancellation.
- On receipt of a suspension or cancellation resolution, check that notification under Article 71 complied with Ley 38 de 2000, and pursue reconsideration and appeal under Article 42 of Ley 90.
- Confirm which bodies were informed under Article 72, since procurement eligibility may be affected independently of the certificate.
5. Verification checklist
- □ Five CCT suspension grounds recorded (Article 66)
- □ Thirteen CCT cancellation grounds recorded (Article 67)
- □ Particular attention given to Article 67, item 2 (change of manufacturer) and item 9 (withdrawal of authority)
- □ Family certificate issues addressed by removal under Article 68
- □ Six-month suspension and cancellation on repetition recorded (Article 69)
- □ Notification of the resolution confirmed against Ley 38 de 2000 (Article 71)
- □ Notification recipients under Article 72 confirmed as covered
How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Panamanian market. Our team manages Ministry of Health (MINSA) sanitary registration applications, prepares Spanish-language dossiers, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us